--:--:--

Akums Drugs and Pharmaceuticals Limited

Web: akums.in NSE: AKUMS BSE: 544222 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

692 18(-3%)

Volume

2L as on 16, Oct

Open

561

High

563

Low

553

Close

710

VWAP

738

52 Week High

839

52 Week Low

409

Viand Research Rating
Quality Score

43/100

Growth Score

16/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

10,892

No. of Shares

15.7

P/E

-

P/B

-

Face Value

2

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

-

ROCE

-

Profit Growth

-

Listing Date

06-Aug-24

Rank/Sector Rank

#529/#54

Promoter Holding

75.26%

FII Holding

1.91%

DII Holding

13.44%

Price Chart
Price Performance
1 Week3%
1 Month5%
3 Months7%
6 Months33%
1 Year57%
YTD64%
Moving Average
5 Day SMA754
10 Day SMA775
20 Day SMA794
30 Day SMA783
50 Day SMA769
61 Day SMA752
80 Day SMA729
200 Day SMA591
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3792757781790
Resistance 2781755771780
Resistance 1765752765763
Pivot Point754750754753
Support 1739747744736
Support 2728745738726
Support 3712742728710
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,18,69817450%5%4%4%3755.50.0711509
2DIVISLAB2,43,96691902%0%45%38%6955.502568
3TORNTPHARM1,73,20845542%5%10%28%7255.51.792138
4ZYDUSLIFE1,11,45111170%1%20%12%2055.50.313560
5APOLLOHOSP1,09,27676002%9%4%1%5855.50.92003
6LAURUSLABS1,08,73820121%8%83%124%055.50.48890
7CIPLA1,06,15413142%2%8%19%2255.50.023862
8DRREDDY1,03,87312443%8%1%4%2055.50.24158
9MANKIND94,40122864%1%8%7%4955.50.391938
10AUROPHARMA90,84115792%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Promoters(0.01) 75.26%(0.01) 75.26%(0.01) 75.26%(0.01) 75.26%(0.01) 75.26%(0.01) 75.26%(0.01) 75.26%(0.01) 75.26%
FIIs(0.51) 1.91%(0.21) 1.38%(-1.11) 1.14%(-2.01) 2.27%(-1.51) 4.24%(-0.61) 5.77%(-1.01) 6.36%(0.01) 7.34%
DIIs(-0.91) 13.44%(-0.11) 14.36%(5.11) 14.41%(0.41) 9.28%(1.51) 8.85%(0.41) 7.39%(-0.51) 6.99%(0.01) 7.53%
Public6.67%6.29%6.45%10.46%8.92%8.84%8.64%7.14%
No. of Shareholders70,28972,58976,86975,36569,42469,36668,41057,531
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales392338369309332329337328317298383447316
Sales Growth % (YoY)18%2.9%9.2%-5.8%4.8%10.2%-11.9%-26.5%0.5%----
Sales Growth % (QoQ)16%-8.4%19.4%-6.9%0.9%-2.4%2.7%3.5%6.4%-22.2%-14.3%41.5%-
Expenses344327344292288311303285274359351358503
Operating Profit491225174418344344-613289-187
OPM %123.575135101314-20820-59
Other Income2625262729323432262525420
Interest2322332465554
Depreciation13121211101011999887
Profit before tax592236316037556254-494381-178
Tax %2430222525262518231832356
Net Profit 451528234528415042-582953-190
Net Profit Growth % (QoQ)200%-46.4%21.7%-48.9%60.7%-31.7%-18%19%172.4%-300%-45.3%127.9%-
Net Profit Growth % (YoY)--46.4%-31.7%-54%7.1%148.3%41.4%-5.7%122.1%----
TTM Net Profit111111124137164161756366-166-108-1370
EPS in Rs2.850.971.791.492.851.752.623.22.84-4.052.053.69-13.26
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016Mar 2015
Sales1349131214441287116283773768359616511464
Sales Growth %2.8%-9.2%12.2%10.7%38.8%13.6%7.9%14.6%-12.8%-
Expenses1251117315701045152481169760352115071340
Operating Profit98139-126242-36227408075144124
OPM %711-919-313.25121398
Other Income10612474-4858-19566585566
Interest10151813414432223
Depreciation4640333028262523233831
Profit before tax148208-103150-335-195761121058977
Tax %2523611714-263333355051
Net Profit 112161-165125-382-1455175686143
Net Profit Growth %-30.4%197.6%-232%132.7%-163.4%-384.3%-32%10.3%11.5%41.9%-
EPS in Rs7.0910.23-11.568.77-53.37-1118.18391.05636.94576.34523.23366.55
Dividend Payout %410000000000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016Mar 2015
Cash from Operating Activity-2912489422856-22008972
Cash from Investing Activity-25-459-165-202-298-100-24200-123-150
Cash from Financing Activity-3375-2190953302003766
Net Cash Flow-30862-1825-4238004-11
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016Mar 2015
Equity Capital31313131292914111111
Reserves2397311822752803115283171566711841766628493
Borrowings59904653026714614041365133213255
Other Liabilities3261920333906168414371488690678153160318293
Total Liabilities281251592685427020951894181412981426104696011611042
Fixed Assets42514213561257317272253244242237236501444
CWIP521585716491611100110
Investments366036601391391411496544180
Other Assets19693580190628501631146614199031118806720632598
Total Assets281251592685427020951894181412981426104696011611042
Delivery

Delivery Data: AKUMS

#Date
685
22%
839
Value (Cr)Q/T
17
Del
50
Del
20
121-Oct694
29
166118
219-Oct710
36
186122
316-Oct731
11
11526
415-Oct750
9
7565
514-Oct770
10
10505
613-Oct769
10
9485
712-Oct751
13
6557
89-Oct752
33
134415
98-Oct787
24
114511
107-Oct823
13
13456
116-Oct815
10
16566
125-Oct801
9
12454
131-Oct813
16
13457
1430-Sep818
16
13539
1529-Sep820
15
10507
1628-Sep800
13
14486
1725-Sep820
13
13506
1824-Sep818
18
155810
1923-Sep823
36
165219
2022-Sep808
21
185111
2121-Sep821
68
213725
2218-Sep784
26
136216
2317-Sep767
17
16569
2416-Sep772
18
185310
2515-Sep766
27
134913
2611-Sep776
31
194915
2710-Sep750
22
75913
289-Sep741
33
205117
298-Sep737
15
17609
307-Sep755
9
14525
314-Sep766
26
165113
323-Sep781
26
185414
332-Sep770
58
276336
341-Sep779
36
225118
3531-Aug777
20
194910
3628-Aug773
31
225919
3727-Aug761
28
205615
3826-Aug766
32
155718
3925-Aug745
19
175210
4024-Aug770
37
194818
4121-Aug750
19
145811
4220-Aug753
32
175919
4319-Aug753
41
195121
4418-Aug744
20
14449
4517-Aug744
23
145412
4614-Aug727
14
14476
4713-Aug752
22
176013
4812-Aug750
27
194713
Daily Market Cap
DateTotal Market CapChangeChg %
21-Oct10,892c230c2.07
19-Oct11,122c384c3.34
17-Oct11,506c00
16-Oct11,506c236c2.01
15-Oct11,742c205c1.71
14-Oct11,946c189c1.56
13-Oct12,135c323c2.73
12-Oct11,812c6c0.05
09-Oct11,818c536c4.34
08-Oct12,354c360c2.83
05-Oct12,714c234c1.81
01-Oct12,948c238c1.87
29-Sep12,710c89c0.70
28-Sep12,621c294c2.28
25-Sep12,916c126c0.97
24-Sep13,042c309c2.42
22-Sep12,733c409c3.32
17-Sep12,324c495c4.18
10-Sep11,829c179c1.49
07-Sep12,008c73c0.61
04-Sep11,935c00
Stock Checklist
Price is above from 52 week high low average: 66%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

Held by 39 fund scheme(s) across 11 fund house(s) as of Oct26 · Total value ₹1,821 Cr · 20 increasing / 7 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
Franklin Templeton Mutual Fund81.64%+0.13%1005.7
Bandhan Mutual Fund60.40%+0.02%275.6
ICICI Prudential Mutual Fund40.65%-0.08%262.7
Nippon India Mutual Fund21.21%+0.10%221.3
Old Bridge Mutual Fund22.79%+0.61%25.2
Motilal Oswal Mutual Fund40.31%+0.04%15.4
Jio BlackRock Mutual Fund10.28%-0.09%8.9
Samco Mutual Fund60.53%+0.53%6.1
Groww Mutual Fund20.01%-0.1
Mirae Asset Mutual Fund20.02%-0
Angel One Mutual Fund20.02%-0
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0